دورية أكاديمية
European Consensus on use of diuretics in chronic heart failure 2019
| العنوان: | European Consensus on use of diuretics in chronic heart failure 2019 |
|---|---|
| المؤلفون: | M. V. Leonova |
| المصدر: | Медицинский совет, Vol 0, Iss 4, Pp 12-21 (2020) |
| بيانات النشر: | Remedium Group LLC, 2020. |
| سنة النشر: | 2020 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | chronic heart failure, decompensation, diuretic therapy, loop diuretics, thiazides, antagonists of mineralocorticoid receptors, Medicine |
| الوصف: | The article presents the consensus materials of the European Society of Cardiology on the use of diuretics in chronic heart failure (CHF). Diuretics represent an important class of drugs for the treatment of heart failure from the perspective of evidence based medicine. Much attention in the consensus s paid to the algorithm of using diuretics, in particular loop diuretics, in acute decompensation of CHF. Clinical and pharmacological advantages and disadvantages of the main drugs of loop diuretics (furosemide, torasemide, bumetanide) in CHF are discussed. There was analyzed the effectiveness of low and high doses of loop diuretics, the method of administration (bolus or continuous infusion) in terms of effective diuretic therapy and prevention of tolerance to diuretics, as well as the impact on the prognosis of survival during decompensation of heart failure. It also discusses modern approaches to the diagnostic criteria for assessing the effectiveness of diuretic therapy in acute decompensation of CHF, and shows the possibility of determination the level of excretion of Na+ ions in the urine as a surrogate marker of the effectiveness of diuretic therapy to optimize the dosage regimen of diuretics. An algorithm of diuretic therapy is proposed (the choice of dosages and regimens for using loop diuretics) for patients with acute decompensation of heart failure, including intravenous use of loop diuretics in an optimal increasing dose for the first 24 hours before stopping stagnation with a further transition to a maintenance dose of loop diuretic for euvolemia status and combined diuretic therapy with thiazides to obtain synergism. The recommendations for correction of electrolyte disturbances against the background of diuretic therapy is considered.Loop diuretics are recommended for CHF to prevent signs and symptoms of congestion: this is the only group of drugs with a level of recommendation as class I in patients with heart failure with a reduced or preserved ejection fraction. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Russian |
| تدمد: | 2079-701X 2658-5790 |
| Relation: | https://www.med-sovet.pro/jour/article/view/5595; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790 |
| DOI: | 10.21518/2079-701X-2020-4-12-21 |
| URL الوصول: | https://doaj.org/article/18d5722d17bf4147b5a4c4f0fd523619 |
| رقم الأكسشن: | edsdoj.18d5722d17bf4147b5a4c4f0fd523619 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 2079701X 26585790 |
|---|---|
| DOI: | 10.21518/2079-701X-2020-4-12-21 |